Cargando…

Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience

BACKGROUND: The recognition of idiopathic membranous nephropathy (IMN) as an autoimmune disease has paved the way for the use of B-cell-depleting agents, such as Rituximab (RTX), which is now a first-line drug for treating IMN with proven safety and efficacy. Nevertheless, the usage of RTX for the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yao-Wei, Wang, Xin-Hui, Wang, Hong-Xia, Yu, Ren-Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923863/ https://www.ncbi.nlm.nih.gov/pubmed/36793628 http://dx.doi.org/10.12998/wjcc.v11.i3.566

Ejemplares similares

Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience
por: Katsuno, Takayuki, et al.
Publicado: (2017)

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
por: Bagchi, Soumita, et al.
Publicado: (2018)

Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
por: Wang, Xiao-Pei, et al.
Publicado: (2016)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study
por: Chen, Xian, et al.
Publicado: (2023)

Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
por: Cortazar, Frank B., et al.
Publicado: (2017)

Two cases of idiopathic membranous nephropathy treated with rituximab
por: Young Yoon, Jae, et al.
Publicado: (2013)

Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
por: Cheong, Jamie, et al.
Publicado: (2018)

Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study
por: Du, Zhao-Qing, et al.
Publicado: (2019)

Rituximab in Membranous Nephropathy
por: Gauckler, Philipp, et al.
Publicado: (2021)

Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities
por: Bayudan, Alexis Mae, et al.
Publicado: (2020)

Ponseti method treatment of neglected idiopathic clubfoot: Preliminary results of a multi-center study in Nigeria
por: Adegbehingbe, Olayinka O, et al.
Publicado: (2017)

Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
por: Ladino, Marco, et al.
Publicado: (2009)

CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2016)

Rituximab for the treatment of refractory anti-glomerular basement membrane disease
por: Yang, Xue-Fen, et al.
Publicado: (2022)

A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up
por: Zhou, Xu-Jie, et al.
Publicado: (2018)

Case report: Successful treatment of refractory membranous nephropathy with telitacicept
por: Zhang, Lei, et al.
Publicado: (2023)

Modified percutaneous transhepatic papillary balloon dilation for patients with refractory hepatolithiasis
por: Liu, Bin, et al.
Publicado: (2020)

Efficacy and safety of modified tetracycline dosing in a quadruple therapy for Helicobacter pylori: A retrospective single center study
por: Sun, Ying-Chao, et al.
Publicado: (2023)

Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Lu, Huijuan, et al.
Publicado: (2022)

Rituximab for the treatment of refractory simultaneous anti-glomerular basement membrane (anti-GBM) and membranous nephropathy
por: Bandak, Ghassan, et al.
Publicado: (2014)

Rituximab in patients with membranous nephropathy and kidney insufficiency
por: Guo, Yanhong, et al.
Publicado: (2022)

Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience
por: Chen, Ping, et al.
Publicado: (2023)

Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency
por: Xia, Wei, et al.
Publicado: (2023)

Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
por: Liang, Jinxiu, et al.
Publicado: (2023)

Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn’s disease in Chinese population
por: Mao, Jing, et al.
Publicado: (2023)

Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
por: Yu, Xiaojuan, et al.
Publicado: (2017)

Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy
por: Xie, Gan, et al.
Publicado: (2017)

Quality indicators in pediatric colonoscopy in a low-volume center: Implications for training
por: Lee, Way-Seah, et al.
Publicado: (2018)

Whipple’s pancreaticoduodenectomy at a resource-poor, low-volume center in Trinidad and Tobago
por: Cawich, Shamir O, et al.
Publicado: (2022)

Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review
por: Jeon, Soo-Jee, et al.
Publicado: (2022)

Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab
por: Wittenberg, Marcel, et al.
Publicado: (2019)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

Successful Corticosteroid-Sparing Effect of Rituximab in the Treatment of Refractory Idiopathic Orbital Inflammatory Disease
por: Shao, Emily H., et al.
Publicado: (2013)

Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
por: Yoshida, Shun, et al.
Publicado: (2020)

Optimal use of fielder XT guidewire enhances the success rate of chronic total occlusion percutaneous coronary intervention
por: Wang, Qian-Cheng, et al.
Publicado: (2019)

Preoperative and postoperative complications as risk factors for delayed gastric emptying following pancreaticoduodenectomy: A single-center retrospective study
por: Xie, Fang-Liang, et al.
Publicado: (2023)

Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study
por: Zhao, Yuchao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4sn1fa8f3pdsv5mq3hicn7q68l